View Document Preview and Link Document Date: 2015-03-05 19:45:55 Open Document File Size: 450,79 KB Share Result on Facebook
City ROSE / ROBBINS ET / Burnaby / / Company Ge / Honda / Diebold / siRNA / Mary Ann Liebert Inc. / / Country Guinea / Canada / / Currency PKR / / Event FDA Phase / / Facility Bridge et al. / RISC complex / ApoB1 duplex / duplex RNA / / IndustryTerm human model systems / machinery / cancer treatment / therapy of melanoma / chemical modification / vivo and therapeutic applications / human systems / chemical composition / chemical modification strategy / lipid delivery technologies / chemical / chemical structure / chemical modification approaches / chemical modifications / / MedicalCondition pathogenic infectious agents / viral infection / HBV / Macular degeneration / inflammatory syndromes / severe acute respiratory syndrome / immediate hypersensitivity / HIV RNA / hepatitis B / inflammatory mediators / melanoma / inflammatory cytokines / choroidal neovascularization / inflammatory cytokine induction / infections / influenza / hypotension / cancer / disease / inflammatory cytokine production / SARS / ebola / chills / predominantly inflammatory cytokine / fever / tumor necrosis / rigors / parainfluenza / infection / eye disease / vesicular stomatitis virus / herpes simplex / syndrome / inflammatory / / MedicalTreatment immunostimulation / / Organization Systemic administration / African Union / / Person Clemens / Chiu / Nat / Morrissey / Ian MacLachlan / Marjorie Robbins / Adam Judge / Forsbach / Jun Type / Rana / Elia / / Position researcher / engineer / FISHER / reporter / Judge / NF-κB reporter / / Product adenosine / STAT1 / / ProvinceOrState Alabama / British Columbia / South Dakota / / Technology alpha / antibodies / siRNA technologies / lipid delivery technologies / Apoptosis / pharmacokinetics / gene expression / / SocialTag 
REVIEW OLIGONUCLEOTIDES Volume 19, Number 2, 2009 © Mary Ann Liebert, Inc. DOI: oli